Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05692245 · ClinicalTrials.gov registry record · Phase 4
Dexamethasone vs Ondansetron After Cesarean Delivery
A Phase 4 study of Cesarean Section Complications and Nausea and Vomiting, Postoperative, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05692245: Completed Phase 4 study of Cesarean Section Complications and Nausea and Vomiting, Postoperative, sponsored by Beth Israel Deaconess Medical Center.
NCT05692245 is a Phase 4 study of Cesarean Section Complications and Nausea and Vomiting, Postoperative that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 100 participants, below the 762-participant average among 9 other Cesarean Section Complications trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05692245, a Phase 4 study of Cesarean Section Complications and Nausea and Vomiting, Postoperative, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare medications in women having a cesarean delivery. The main question it aims to answer are: • Which medication is better to use as a first-line prevention agent for nausea and vomiting Participants will rate their nausea, pain and other symptoms after surgery Researchers will compare two drugs, ondansetron and dexamethasone to see if the side effects of pain medications are improved after cesarean.
Primary Outcome
Total number of unscheduled medications administered by nurses to patients and received in the 24 hours after cesarean for the treatment of Nausea, vomiting, pruritus or pain
Conditions Studied
Interventions
- DRUG Dexamethasone
- DRUG Ondansetron
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-03-30 |
| Est. Completion | 2024-04-30 |
| Phase | Phase 4 |
What the finished NCT05692245 record still lists
NCT05692245 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 762-participant average among 9 other Cesarean Section Complications trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Cesarean Section Complications appearing as the primary indexed condition, and to 2 interventions - of which Dexamethasone is the first listed.
NCT05692245 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05692245 about?
NCT05692245 is a clinical study titled "Dexamethasone vs Ondansetron After Cesarean Delivery". The goal of this clinical trial is to compare medications in women having a cesarean delivery. The main question it aims to answer are: • Which medication is better to use as a first-line prevention agent for nausea and vomiting Participants will rate their nausea, pain and other symptoms after sur...
What is the current status of trial NCT05692245?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2023-03-30. Estimated completion is 2024-04-30.
What conditions does trial NCT05692245 study?
This clinical trial studies the following conditions: Cesarean Section Complications, Nausea and Vomiting, Postoperative.
What interventions are being tested in trial NCT05692245?
The interventions under investigation include: Dexamethasone (DRUG), Ondansetron (DRUG).
Who is sponsoring clinical trial NCT05692245?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05692245 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cesarean Section Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05692245's enrollment target sits among peer trials
100 7th of 9 higher than 1 of 9 other Cesarean Section Complications trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cesarean Section Complications trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ESP Block for Post Cesarean Analgesia
COMPLETED · Phase 4
-
Oxytocin Pharmacokinetics and Pharmacodynamics
RECRUITING · Phase 2
-
Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)
RECRUITING · NA
-
Durometer for Measuring Uterine Tone
RECRUITING · NA
-
Personalized Perioperative Analgesia Platform (PPAP) for Cesarean Section
RECRUITING · NA
-
Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI